230 Publications (Page 8 of 10)
2010
Non-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed model.
Wang, Zhiping⋅Kim, Seongho⋅Quinney, Sara K⋅Zhou, Jihao and Li, Lang
BMC systems biology, vol. 4 Suppl 1, pp. S8, 2010. | Journal Article
 
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.
Quinney, Sara K⋅Zhang, Xin⋅Lucksiri, Aroonrut⋅Gorski, J C⋅Li, Lang and Hall, Stephen D
Drug metabolism and disposition: the biological fate of chemicals, vol. 38, (no. 2), pp. 241-8, 2010/Feb. | Journal Article
 
Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin. Drug Metabolism and Disposition
. | Journal Article
2009
A new probabilistic rule for drug-dug interaction prediction.
Zhou, Jihao⋅Qin, Zhaohui⋅Quinney, Sara K⋅Kim, Seongho⋅Wang, Zhiping⋅Yu, Menggang⋅Chien, Jenny Y⋅Lucksiri, Aroonrut⋅Hall, Stephen D and Li, Lang
Journal of pharmacokinetics and pharmacodynamics, vol. 36, (no. 1), pp. 1-18, 2009/Feb. | Journal Article
 
A new probabilistic rule for drug-dug interaction prediction. Journal of Pharmacokinetics and Pharmacodynamics
. | Journal Article
 
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.
Miao, J⋅Jin, Y⋅Marunde, R L⋅Kim, S⋅Gorski, C J⋅Quinney, Sara K⋅Kim, S⋅Radovich, Milan⋅Quinney, S⋅Radovich, M⋅Li, L⋅Li, L⋅Hall, S D and Hall, S D
The pharmacogenomics journal, vol. 9, (no. 5), pp. 319-26, 2009/Oct. | Journal Article
 
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo. The Pharmacogenomics Journal
. | Journal Article
 
CYP3A GENE CLUSTER ANALYSIS AND MIDAZOLAM PHARMACOKINETICS
Quinney, S. K.⋅Miao, J.⋅Jin, Y.⋅Radovich, M.⋅Kim, S.⋅Li, L. and Hall, S. D.
Clinical Pharmacology & Therapeutics, vol. 85, pp. S25. | Journal Article
 
CYP3A GENE CLUSTER ANALYSIS AND MIDAZOLAM PHARMACOKINETICS
Quinney, S. K.⋅Miao, J.⋅Jin, Y.⋅Radovich, M.⋅Kim, S.⋅Li, L. and Hall, S. D.
(pp. S25)
 
CYP3A GENE CLUSTER ANALYSIS AND MIDAZOLAM PHARMACOKINETICS. Clinical Pharmacology & Therapeutics
. | Journal Article
 
DOCUMENT RANKING METHOD BASED ON MULTI-FEATURE COMBINATION IN LITERATURE MINING ON PHARMACOKINETICS NUMERICAL DATA
Zhao, Y.⋅Wang, Z.⋅Kim, S.⋅Quinney, S. K. and Li, L.
(pp. S83)
 
DOCUMENT RANKING METHOD BASED ON MULTI-FEATURE COMBINATION IN LITERATURE MINING ON PHARMACOKINETICS NUMERICAL DATA
Zhao, Y.⋅Wang, Z.⋅Kim, S.⋅Quinney, S. K. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 85, pp. S83. | Journal Article
 
DOCUMENT RANKING METHOD BASED ON MULTI-FEATURE COMBINATION IN LITERATURE MINING ON PHARMACOKINETICS NUMERICAL DATA. Clinical Pharmacology & Therapeutics
. | Journal Article
 
Drug-drug interaction prediction assessment
Zhou, Jihao⋅Zhou, J.⋅Qin, Zhaohui S⋅Qin, Z.⋅Sara, Quinney K⋅Sara, Q.K.⋅Kim, Seongho⋅Kim, S.⋅Wang, Zhiping⋅Wang, Z.⋅Hall, Stephen D⋅Hall, S.D.⋅Li, Lang and Li, L.
Journal of Biopharmaceutical Statistics, vol. 19, pp. 641-657. | Journal Article
 
INHIBITION MODEL INFLUENCES K-i ESTIMATE FOR KETOCONAZOLE
Quinney, S. K.⋅Hall, S. D. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 85, pp. S25. | Journal Article
 
INHIBITION MODEL INFLUENCES K-i ESTIMATE FOR KETOCONAZOLE
Quinney, S. K.⋅Hall, S. D. and Li, L.
(pp. S25)
 
INHIBITION MODEL INFLUENCES K-i ESTIMATE FOR KETOCONAZOLE. Clinical Pharmacology & Therapeutics
. | Journal Article
 
IN VITRO IN VIVO PREDICTION OF CLEARANCE AND ITS VARIABILITY: A MIDAZOLAM CASE STUDY
Quinney, S. K.⋅Feng, W.⋅Kim, S.⋅Hall, S. D. and Li, L.
(pp. S25-S26)
 
IN VITRO IN VIVO PREDICTION OF CLEARANCE AND ITS VARIABILITY: A MIDAZOLAM CASE STUDY
Quinney, S. K.⋅Feng, W.⋅Kim, S.⋅Hall, S. D. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 85, pp. S25-S26. | Journal Article
 
IN VITRO IN VIVO PREDICTION OF CLEARANCE AND ITS VARIABILITY: A MIDAZOLAM CASE STUDY. Clinical Pharmacology & Therapeutics
. | Journal Article
 
Literature mining on pharmacokinetics numerical data: a feasibility study.
Wang, Zhiping⋅Kim, Seongho⋅Quinney, Sara K⋅Guo, Yingying⋅Hall, Stephen D⋅Rocha, Luis M and Li, Lang
Journal of biomedical informatics, vol. 42, (no. 4), pp. 726-35, 2009/Aug. | Journal Article
 
Literature mining on pharmacokinetics numerical data: A feasibility study. Journal of Biomedical Informatics
. | Journal Article
 
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
Zhang, Xin⋅Quinney, Sara K⋅Gorski, J C⋅Jones, David R and Hall, Stephen D
Drug metabolism and disposition: the biological fate of chemicals, vol. 37, (no. 8), pp. 1587-97, 2009/Aug. | Journal Article
 
Semiphysiologically Based Pharmacokinetic Models for the Inhibition of Midazolam Clearance by Diltiazem and Its Major Metabolite. Drug Metabolism and Disposition
. | Journal Article
2008
Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats.
Quinney, Sara K⋅Galinsky, Raymond E⋅Jiyamapa-Serna, Vanida A⋅Chen, Yong⋅Hamman, Mitchell A⋅Hall, Stephen D and Kimura, Robert E
Drug metabolism and disposition: the biological fate of chemicals, vol. 36, (no. 6), pp. 1097-101, 2008/Jun. | Journal Article